Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,288.00
(
0.64%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.97
(
-0.68%
)
Bitcoin
74,044.88
(
0.14%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

zipjet

Send PM Follow Ignore
Followers 36
Posts 2637
Boards Moderated 0
Alias Born 10/06/2003

zipjet

Re: None

Tuesday, 04/29/2008 10:05:10 PM

Tuesday, April 29, 2008 10:05:10 PM

Post# of 257253
MNTA news


It seems to me that one of the interesting questions remaining open is whether FDA has provided parallel guidance to Teva and/or Amphastar. If so, then it is still a horse race and multiple approvals are still possible. If not, then MNTA may have taken a significant lead in the race to approval and sole approval becomes a more likely outcome.

ij

There are times when rules and precedents cannot be broken; others when they cannot be adhered to with safety. (Thomas Joplin)

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now